Results are presented of radon concentrations in 12 houses 10 years after radon mitigation measures were implemented to reduce elevated radon concentrations in the houses. The houses were part of an earlier radon research project in which the home-owners received remediation advice from radon researchers, and a single contractor carried out the reduction measures. Remediation in nine of the houses was principally by installing an internal sump, in another by installing an external sump, in one by ventilating the crawl-space under the house, and one house had had a naturally ventilated sump system built into the house and later had a fan installed to increase the sub-slab depressurization. The measurements showed that ten years after radon reduction measures were implemented, only 3 of 12 houses had radon concentrations under the present-day action level of 200 Bq·m–3 (5.4 pCi·l–1) in Norway. The results suggest that radon levels should be measured at periodic intervals after remediation, perhaps once every five years, to ensure that concentrations continue to be at acceptable levels.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.